Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
July 3, 2023
Clinical Translation of Targeted Protein Degraders
Nikki R Kong, Lyn H Jones
Critical Reviews in Oncogenesis
|
December 14, 2011
The role of stem cell factor SALL4 in leukemogenesis
Chong Gao, Nikki R Kong, Li Chai
ACS Medicinal Chemistry Letters
|
November 19, 2021
Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition
Nikki R Kong, Hu Liu, Jianwei Che, et al.
Plos Genetics
|
February 23, 2016
MEF2C and EBF1 Co-regulate B Cell-Specific Transcription
Nikki R Kong, Matthew Davis, Li Chai, et al.
Gene
|
February 20, 2016
SALL4, the missing link between stem cells, development and cancer
Hiro Tatetsu, Nikki R Kong, Gao Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 26, 2006
Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia
Wei Cui, Nikki R Kong, Yupo Ma, et al.
Development (Cambridge, England)
|
April 10, 2014
Spalt-like 4 promotes posterior neural fates via repression of pou5f3 family members in Xenopus
John J Young, Rachel A S Kjolby, Nikki R Kong, et al.
RSC Medicinal Chemistry
|
March 27, 2023
Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives
Radosław P Nowak, Jianwei Che, Silas Ferrao, et al.
Transfusion
|
September 1, 2012
SALL4 is a key transcription regulator in normal human hematopoiesis
Chong Gao, Nikki R Kong, Ailing Li, et al.
Nature Methods
|
March 2, 2021
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia
Jonathan D Lee, Joao A Paulo, Ryan R Posey, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
July 3, 2023
Clinical Translation of Targeted Protein Degraders
Nikki R Kong, Lyn H Jones
Critical Reviews in Oncogenesis
|
December 14, 2011
The role of stem cell factor SALL4 in leukemogenesis
Chong Gao, Nikki R Kong, Li Chai
ACS Medicinal Chemistry Letters
|
November 19, 2021
Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition
Nikki R Kong, Hu Liu, Jianwei Che, et al.
Plos Genetics
|
February 23, 2016
MEF2C and EBF1 Co-regulate B Cell-Specific Transcription
Nikki R Kong, Matthew Davis, Li Chai, et al.
Gene
|
February 20, 2016
SALL4, the missing link between stem cells, development and cancer
Hiro Tatetsu, Nikki R Kong, Gao Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 26, 2006
Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia
Wei Cui, Nikki R Kong, Yupo Ma, et al.
Development (Cambridge, England)
|
April 10, 2014
Spalt-like 4 promotes posterior neural fates via repression of pou5f3 family members in Xenopus
John J Young, Rachel A S Kjolby, Nikki R Kong, et al.
RSC Medicinal Chemistry
|
March 27, 2023
Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives
Radosław P Nowak, Jianwei Che, Silas Ferrao, et al.
Transfusion
|
September 1, 2012
SALL4 is a key transcription regulator in normal human hematopoiesis
Chong Gao, Nikki R Kong, Ailing Li, et al.
Nature Methods
|
March 2, 2021
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia
Jonathan D Lee, Joao A Paulo, Ryan R Posey, et al.
Page
of 2